Status:

TERMINATED

Metabolic Sodium MRI to Assess Early Response of Breast Cancer to Neoadjuvant Chemotherapy

Lead Sponsor:

NYU Langone Health

Collaborating Sponsors:

National Institutes of Health (NIH)

Conditions:

Breast Cancer

Triple Negative Breast Cancer

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Neoadjuvant chemotherapy (NACT) is administered to treat invasive breast cancer before surgery. It offers the opportunity to evaluate tumor response to treatment in aggressive disease, and guide addit...

Eligibility Criteria

Inclusion

  • Women with no sign of breast cancer as controls
  • Non-pregnant and non-lactating
  • Ability to understand and willingness to sign a written consent

Exclusion

  • Contra-indications to MRI (i.e., ferromagnetic prostheses, metallic surgical implants that are not compatible with an MRI machine, claustrophobia etc.)
  • Medical condition such as uncontrolled infection (including HIV), uncontrolled diabetes mellitus or cardiac disease which, in the opinion of the treating physician, would make this protocol unreasonably hazardous for the patient.
  • Pregnant or lactating women, women using hormonal treatment in the 6 months prior to the study.
  • Women with history of breast disease, previous breast surgery, or breast implants.
  • Patients with a currently active second malignancy other than non-melanoma skin cancers. Patients are not considered to have a currently active malignancy if they have completed therapy and are free of disease for 3 years.
  • Psychiatric illness or other conditions and circumstances which could prevent the patient from being compliant with the protocol.

Key Trial Info

Start Date :

July 25 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 24 2021

Estimated Enrollment :

2 Patients enrolled

Trial Details

Trial ID

NCT03750240

Start Date

July 25 2017

End Date

June 24 2021

Last Update

August 24 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NYU Langone Health

New York, New York, United States, 10016